Quellhorst E, Schuenemann B, Borghardt J
Artif Organs. 1978 Nov;2(4):334-8. doi: 10.1111/j.1525-1594.1978.tb01616.x.
The removal of uremic substances in hemofiltration, in contrast to hemodialysis, is achieved by means of a convective transport across membranes of high porosity. Since 1974, more than 30 patients with chronic renal insufficiency have been treated with regular hemofiltration three times weekly for four to five hours each. After completing a pilot study, a controlled study to compare hemodialysis and hemofiltration was initiated during January, 1978. A normalization of blood pressure in patients with severe hypertension, and remarkable stability of the circulatory system, even after dehydration in patients who had hypotension in spite of fluid overload, could be demonstrated. Hemofiltration is preferred, especially in older patients with cardiovascular or cerebrovascular problems, because of its lower frequency of hypotensive episodes compared to dialysis. An important aim--the miniaturization of the artificial kidney--has not yet been achieved, however, because of the necessity for an extensive monitoring system for the exact proportioning of the sterile substitution fluid. First results in the application of a fluid regeneration system consising of a charcoal cartridge and a bioelectric cell, for degradation of urea, are presented.
与血液透析不同,血液滤过中尿毒症物质的清除是通过对流运输穿过高孔隙率的膜来实现的。自1974年以来,30多名慢性肾功能不全患者接受了每周三次、每次四到五小时的常规血液滤过治疗。在完成一项试点研究后,1978年1月启动了一项比较血液透析和血液滤过的对照研究。结果表明,重度高血压患者的血压恢复正常,即使是那些尽管液体超负荷但仍有低血压的患者在脱水后,循环系统也具有显著的稳定性。由于与透析相比,血液滤过引起低血压发作的频率较低,因此血液滤过更受青睐,尤其是对于患有心血管或脑血管问题的老年患者。然而,由于需要一个广泛的监测系统来精确配比无菌置换液,人工肾小型化这一重要目标尚未实现。本文介绍了首次将由活性炭柱和生物电池组成的液体再生系统用于尿素降解的研究结果。